Galmed Pharmaceuticals (GLMD) Institutional Ownership $2.73 +0.18 (+6.90%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$2.72 -0.01 (-0.22%) As of 02/21/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$81.03KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$808.57K Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025 Schonfeld Strategic Advisors LLC25,400$81K0.0%N/A3.969% 5/7/2024CVI Holdings LLC74,665$25K0.0%-72.3%1.479% 8/15/2023 BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023 BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022 Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022 Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% 11/16/2021 Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% 11/16/2021 Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021 Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021 Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021 Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021 Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% 8/5/2021 Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868% 7/31/2021 Brave Asset Management Inc.11,470$35K0.0%N/A0.046% 5/19/2021 Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219% 5/17/2021 Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105% 5/14/2021 Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838% 5/13/2021 Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242% 3/26/2021 Susquehanna International Group LLP10,483$33K0.0%N/A0.042% 2/16/2021 Squarepoint Ops LLC21,010$65K0.0%-12.5%0.100% 2/16/2021 Baker BROS. Advisors LP184,927$575K0.0%-10.0%0.876% 2/10/2021 Renaissance Technologies LLC115,800$360K0.0%+238.2%0.548% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), and Schonfeld Strategic Advisors LLC ($81K), CVI Holdings LLC ($25K).Learn more on GLMD's institutional investors. What percentage of Galmed Pharmaceuticals stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which institutional investors have been buying Galmed Pharmaceuticals stock? The following institutional investors have purchased Galmed Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($25.40K). How much institutional buying is happening at Galmed Pharmaceuticals? Institutional investors have bought a total of 25,400 shares in the last 24 months. This purchase volume represents approximately $81.03K in transactions. Which Galmed Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Galmed Pharmaceuticals stock in the last 24 months: BVF Inc. IL ($1.65M), and CVI Holdings LLC ($194.57K). How much institutional selling is happening at Galmed Pharmaceuticals? Institutional investors have sold a total of 1,844,390 shares in the last 24 months. This volume of shares sold represents approximately $74.82M in transactions. Related Companies GLTO Institutional Ownership APM Institutional Ownership VRAX Institutional Ownership CMND Institutional Ownership SNGX Institutional Ownership ONVO Institutional Ownership ABVC Institutional Ownership ALZN Institutional Ownership CANF Institutional Ownership ELAB Institutional Ownership This page (NASDAQ:GLMD) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
